MedTrace Logo

GlobalSurg-CovidSurg Week

NCT04509986 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2020-08-12

No results posted yet for this study

Summary

Observational study to determine the optimal timing for surgery following SARS-CoV-2 infection and assess key global surgery indicators.

Conditions

  • Surgery
  • Covid19
  • Post-Op Complication

Sponsors & Collaborators

  • National Institute for Health Research (NIHR) Global Health Research Unit Grant (NIHR 16.136.79)

    collaborator UNKNOWN

  • Association of Coloproctology of Great Britain and Ireland

    collaborator UNKNOWN

  • Bowel & Cancer Research

    collaborator UNKNOWN

  • Association of Upper Gastrointestinal Surgeons; British Association of Surgical Oncology

    collaborator UNKNOWN

  • Bowel Disease Research Foundation

    collaborator UNKNOWN

  • British Gynaecological Cancer Society

    collaborator UNKNOWN

  • European Society of Coloproctology

    collaborator UNKNOWN

  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV

  • Sarcoma UK

    collaborator UNKNOWN

  • Vascular Society for Great Britain and Ireland

    collaborator UNKNOWN

  • Yorkshire Cancer Research

    collaborator OTHER

  • University of Birmingham

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2020-10-31
Completion
2020-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04509986 on ClinicalTrials.gov